VAERS reports by lot

Pfizer COVID-19 lot ENG199: VAERS reports

30 VAERS reports list lot ENG199 as a Pfizer COVID-19 vaccine, received between 2021-03-05 and 2024-12-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
17%
Marked serious
2
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4423%
Cardiac / Cardiovascular4322%
Neurological2312%
Musculoskeletal2211%
Respiratory168%
Gastrointestinal168%
Thrombotic / Hematological95%
Allergic / Anaphylactic95%
Dermatological (non-injection-site)42%
Psychiatric / Neuropsychiatric32%
Injection-site / Local reaction32%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
Florida5
Washington4
Massachusetts2
Oregon1
New York1
Georgia1
Utah1
Texas1
Illinois1
Virginia1
Connecticut1

Reports by month received

2021-0315
2021-042
2021-052
2021-082
2021-091
2021-101
2022-013
2022-031
2022-041
2023-111
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.